These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 11980652

  • 1. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y, McCadden J, Ferrer F, Kruszewski M, Carducci M, Simons J, Rodriguez R.
    Cancer Res; 2002 May 01; 62(9):2576-82. PubMed ID: 11980652
    [Abstract] [Full Text] [Related]

  • 2. Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells.
    Peng W, Chen J, Huang YH, Sawicki JA.
    Gene Ther; 2005 Nov 01; 12(21):1573-80. PubMed ID: 16034457
    [Abstract] [Full Text] [Related]

  • 3. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP, Searle PF, Mautner V, James ND.
    Cancer Res; 2000 Jan 15; 60(2):334-41. PubMed ID: 10667585
    [Abstract] [Full Text] [Related]

  • 4. Prostate-specific targeting using PSA promoter-based lentiviral vectors.
    Yu D, Chen D, Chiu C, Razmazma B, Chow YH, Pang S.
    Cancer Gene Ther; 2001 Sep 15; 8(9):628-35. PubMed ID: 11593331
    [Abstract] [Full Text] [Related]

  • 5. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
    Suzuki S, Tadakuma T, Asano T, Hayakawa M.
    Cancer Res; 2001 Feb 15; 61(4):1276-9. PubMed ID: 11245419
    [Abstract] [Full Text] [Related]

  • 6. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.
    Lee SE, Jin RJ, Lee SG, Yoon SJ, Park MS, Heo DS, Choi H.
    Anticancer Res; 2000 Feb 15; 20(1A):417-22. PubMed ID: 10769689
    [Abstract] [Full Text] [Related]

  • 7. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.
    Wu L, Matherly J, Smallwood A, Adams JY, Billick E, Belldegrun A, Carey M.
    Gene Ther; 2001 Sep 15; 8(18):1416-26. PubMed ID: 11571582
    [Abstract] [Full Text] [Related]

  • 8. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
    Kraaij R, van der Weel L, de Ridder CM, van der Korput HA, Zweistra JL, van Rijswijk AL, Bangma CH, Trapman J.
    Prostate; 2007 Jun 01; 67(8):829-39. PubMed ID: 17394196
    [Abstract] [Full Text] [Related]

  • 9. A novel method for the determination of basal gene expression of tissue-specific promoters: an analysis of prostate-specific promoters.
    van der Poel HG, McCadden J, Verhaegh GW, Kruszewski M, Ferrer F, Schalken JA, Carducci M, Rodriguez R.
    Cancer Gene Ther; 2001 Dec 01; 8(12):927-35. PubMed ID: 11781655
    [Abstract] [Full Text] [Related]

  • 10. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer.
    Gotoh A, Ko SC, Shirakawa T, Cheon J, Kao C, Miyamoto T, Gardner TA, Ho LJ, Cleutjens CB, Trapman J, Graham FL, Chung LW.
    J Urol; 1998 Jul 01; 160(1):220-9. PubMed ID: 9628654
    [Abstract] [Full Text] [Related]

  • 11. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S, Shimura S, Nasu Y, Kaku H, Kumon H, Yang G, Wang J, Timme TL, Aguilar-Cordova E, Thompson TC.
    Prostate Cancer Prostatic Dis; 2002 Jul 01; 5(4):316-25. PubMed ID: 12627218
    [Abstract] [Full Text] [Related]

  • 12. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 13. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW.
    Cancer Gene Ther; 2004 Feb 01; 11(2):148-55. PubMed ID: 14695756
    [Abstract] [Full Text] [Related]

  • 14. Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A.
    Zheng JY, Chen D, Chan J, Yu D, Ko E, Pang S.
    Cancer Gene Ther; 2003 Oct 01; 10(10):764-70. PubMed ID: 14502229
    [Abstract] [Full Text] [Related]

  • 15. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 1999 May 01; 59(9):2136-41. PubMed ID: 10232600
    [Abstract] [Full Text] [Related]

  • 16. Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors.
    Peng W, Anderson DG, Bao Y, Padera RF, Langer R, Sawicki JA.
    Prostate; 2007 Jun 01; 67(8):855-62. PubMed ID: 17427200
    [Abstract] [Full Text] [Related]

  • 17. Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene.
    Pang S.
    Cancer Gene Ther; 2000 Jul 01; 7(7):991-6. PubMed ID: 10917201
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.
    Xie X, Zhao X, Liu Y, Zhang J, Matusik RJ, Slawin KM, Spencer DM.
    Cancer Res; 2001 Sep 15; 61(18):6795-804. PubMed ID: 11559553
    [Abstract] [Full Text] [Related]

  • 19. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
    Matsubara S, Wada Y, Gardner TA, Egawa M, Park MS, Hsieh CL, Zhau HE, Kao C, Kamidono S, Gillenwater JY, Chung LW.
    Cancer Res; 2001 Aug 15; 61(16):6012-9. PubMed ID: 11507044
    [Abstract] [Full Text] [Related]

  • 20. Human prostate cancer progression models and therapeutic intervention.
    Chung LW, Kao C, Sikes RA, Zhau HE.
    Hinyokika Kiyo; 1997 Nov 15; 43(11):815-20. PubMed ID: 9436028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.